Website of the Department of Health

HIV post-exposure prophylaxis: guidance from the UK Chief Medical Officers' Expert Advisory Group on AIDS

This document provides updated guidance on occupational HIV post-exposure prophylaxis (PEP) from the UK Chief Medical Officers' Expert Advisory Group on AIDS (EAGA) issued in February 2004 and the interim update following the withdrawal of Viracept (nelfinavir) published in July 2007. It should be read in conjunction with local needlestick injury policy.

31 October 2008

Erratum: The formulation of Truvada is stated incorrectly in Annex C, paragraph 5 on page 43 of the printed copies. It has been corrected in the downloadable version below. The correct text is:
 
One Truvada tablet (245mg tenofovir and 200mg emtricitabine (FTC)) once a day.

• Download Guidance from the Expert Advisory Group on AIDS (PDF, 439K)
• Download equality impact assessment (PDF, 158K)